Some blood pressure medications are not the best choice anymore, either due to their side effects or limited effectiveness.

The SAGER guidelines (Sex and Gender Equity in Research) address the use of the terms sex and gender 8 and the value of designing studies to generate and report data on the basis of sex and gender.

Specifically, we will address current knowledge, controversies and emerging evidence in relation to cardiovascular (CV ... across users of these particular drugs is much greater. It is worthy to note ...

Identifying patients with chest pain that is of cardiac origin is crucial owing to the high mortality and morbidity of cardiovascular diseases. History, electrocardiogram, and cardiac biomarkers are ...

HRS-5346 is currently in a Phase 2 clinical trial in China and targets Lipoprotein(a), a genetically determined and independent risk factor for atherosclerotic cardiovascular disease ... pending the ...

Ochsner Health Medical Director for Cardiac Rehabilitation and Preventive Cardiology, Carl J. "Chip" Lavie, Jr., MD, recently co-authored a groundbreaking research study featured in the prestigious ...

Aims Cardiovascular (CV) deaths were reduced by atorvastatin during a 16-year follow-up of participants in the ...

VPDs with very short coupling intervals developing during an acute stage of myocardial infarction would predict the development of early cycled reentry, potentially culminating in VF, and requires ...

In this review we consider the effects of orlistat on cardiovascular disease (CVD) risk factors. Furthermore, we present the effects of the combination of orlistat with hypolipidemic drugs ...

In a strategic move for medical research and innovation, Duke-NUS Medical School and the National University of Singapore Yong Loo Lin School of Medicine (NUS Medicine) have launched the Systems ...

Idorsia Ltd (SIX: IDIA) today announced the publication of the Annual Report 2024 - consisting of the Business Report, ...